Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds
Authors:
- Lawrence A. LaveryLLLawrence A. Lavery
- Andrew J.M. BoultonABAndrew J.M. Boulton
- 1 June 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 195 (6) , 782-788
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The global burden of diabetic foot diseaseThe Lancet, 2005
- Health-Economic Consequences of Diabetic Foot LesionsClinical Infectious Diseases, 2004
- The Cost Effectiveness of Apligraf?? Treatment of Diabetic Foot UlcersPharmacoEconomics, 2003
- Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countriesJournal of Wound Care, 2002
- Cost effectiveness of Becaplermin in the treatment of diabetic foot ulcers in four European countries.PharmacoEconomics, 2001
- Health-related quality of life in patients with diabetes mellitus and foot ulcersJournal of Diabetes and its Complications, 2000
- Costs of Deep Foot Infections in Patients with Diabetes MellitusPharmacoEconomics, 2000
- Incidence, outcomes, and cost of foot ulcers in patients with diabetes.Diabetes Care, 1999
- Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputationDiabetes Care, 1998
- Diabetic foot ulcers in a multidisciplinary setting An economic analysis of primary healing and healing with amputationJournal of Internal Medicine, 1994